UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010233 |
|---|---|
| Receipt number | R000011981 |
| Scientific Title | Palliative effect of interaperitoneal administration of triamcinolone acetonide in patients with malignant peritonitis |
| Date of disclosure of the study information | 2013/03/13 |
| Last modified on | 2017/03/20 11:03:36 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Palliative effect of interaperitoneal administration of triamcinolone acetonide in patients with malignant peritonitis
Acronym
Intraperotoneal administration of Kenacolt
Scientific Title
Palliative effect of interaperitoneal administration of triamcinolone acetonide in patients with malignant peritonitis
Scientific Title:Acronym
Intraperotoneal administration of Kenacolt
Region
| Japan |
Condition
Condition
refractory patients with malignant peritonitis
Classification by specialty
| Hematology and clinical oncology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the efficacy of intraperitoneal administration of triamcinolone acetonide
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Time to the next abdominal puncture
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Triamcinolone acetonide
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 99 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. Refractory malignant peritonitis required the abdoninal puncture over twice per two weeks
2. not indicated patinets with chemotherapy
3. life ecpectancy less than 6 months
4. more than 20 years old
5. Written informed consent
Key exclusion criteria
1. bloody ascitis
2. infectious peritonitis
3. in controlled diabetes mellitus (HbA1c; more than 8.5%)
4. Pregnant or breast feeding woman
5. Not available for follow-up assesments or unable to comply with study
Target sample size
27
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Koji Takeda |
Organization
Osaka City General Hospital
Division name
Dept. of Clinical Oncology
Zip code
Address
2-13-22, Miyakojimahondohri, Miyakojima-ku, Osaka, Japan
TEL
06-6929-1221
ko-takeda@med.osakacity-hp.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Hirofumi Katayama |
Organization
Osaka City General Hospital
Division name
Dept. of palliative amedicine
Zip code
Address
2-13-22, Miyakojimahondohri, Miyakojima-ku, Osaka, Japan
TEL
06-6929-1221
Homepage URL
ko-takeda@med.osakacity-hp.or.jp
Sponsor or person
Institute
Koji Takeda
Institute
Department
Personal name
Funding Source
Organization
Dept.of Clincial Oncology, Osaka City General Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 03 | Month | 13 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
No patients was entered in this study.
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2013 | Year | 02 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 03 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 03 | Month | 13 | Day |
Last modified on
| 2017 | Year | 03 | Month | 20 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011981
